Goldman Sachs raises target for Thermo Fisher stock to USD 780
Published on 10/02/2026 at 15:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Thermo Fisher Scientific Inc. (ISIN US8835561023) was trading at EUR 584.70 at Lang & Schwarz on October 2, 2026 at 3:34 p.m. CEST, up 0.52 percent from the EUR 581.70 prior close. According to Yahoo Finance on September 21, 2026, Goldman Sachs raised its price target from USD 650.00 to USD 780.00 and maintained a Buy rating.
Revenue growth supports the upgrade
Yahoo Finance reported that Thermo Fisher generated USD 11.99 billion in revenue in the second quarter of 2026, an increase of 10.00 percent from the same quarter a year earlier. Organic revenue growth was 5.00 percent, giving the target increase a clearer operating backdrop than a valuation argument alone.
The company also posted adjusted earnings per share of USD 6.03 in the second quarter of 2026, up 13.00 percent year over year. Adjusted operating income reached USD 2.73 billion, while the adjusted operating margin expanded to 22.80 percent from the prior-year period.
Demand recovery remains uneven
At the September 15, 2026 Morgan Stanley healthcare conference, Investing.com reported that management described second-quarter organic growth of 5.00 percent and first-half 2026 organic growth of 3.00 percent. Pharma Services and biotech, which management said represent about 60 percent of revenue, showed mid-single-digit growth, while China remained a headwind in academic and government spending.
The operating picture matters because management tied the improved outlook to customer demand, acquisitions and stronger end markets. The same conference account said orders were running ahead of revenue, while the company expected full-year 2026 organic growth of 4.00 percent and a return to stronger growth in 2027.
Next results arrive October 21
Thermo Fisher will release its third-quarter 2026 results before the market opens on October 21, 2026, according to Thermo Fisher Scientific. The date gives investors a defined checkpoint for testing whether the 10.00 percent second-quarter revenue growth can carry into the second half.
On the NYSE, TMO was last at USD 658.22 on October 2, 2026 at 9:42 a.m. EDT. The quote was within the USD 435.27 to USD 683.63 52-week range, and the company had a market capitalization of USD 243.4 billion as of October 2, 2026. The further course of trading is shown by the continuously updated real-time quote of Thermo Fisher Scientific stock.
Thermo Fisher Scientific stock facts
- Company: Thermo Fisher Scientific Inc.
- ISIN: US8835561023
- Ticker: TMO
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 2, 2026, 3:34 p.m. CEST): EUR 584.70
- Change versus prior close: plus 0.52 percent
- Prior close Lang & Schwarz (October 1, 2026): EUR 581.70
- Market capitalization: USD 243.4 billion (as of October 2, 2026)
- 52-week range: USD 435.27-683.63 (as of October 2, 2026)
- Sector / Industry: Healthcare / Life Sciences Tools & Services
- Next earnings date: October 21, 2026
